𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antifungal prophylaxis during remission induction therapy for acute leukemia fluconazole versus intravenous amphotericin B

✍ Scribed by Gerald P. Bodey; Elias J. Anaissie; Linda S. Elting; Elihu Estey; Susan O'Brien; Hagop Kantarjian

Book ID
102672546
Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
697 KB
Volume
73
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Liposomal amphotericin B versus the comb
Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction : Chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome
✍ Gloria N. Mattiuzzi; Elihu Estey; Issam Raad; Francis Giles; Jorge Cortes; Yu Sh πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 94 KB

## Abstract ## BACKGROUND Fungal infections are a major cause of morbidity and mortality in patients undergoing induction chemotherapy for acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). The authors evaluated the efficacy and toxicity of liposomal amphotericin B (L‐AmB) compar

Failure of fluconazole prophylaxis to re
Failure of fluconazole prophylaxis to reduce mortality or the requirement of systemic amphotericin B therapy during treatment for refractory acute myeloid leukemia : Results of a prospective randomized Phase III study
✍ Wolfgang Kern; Gerhard Behre; Thomas Rudolf; Andrea Kerkhoff; Albert Grote-Metke πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 126 KB πŸ‘ 2 views

Invasive fungal infections have increasingly become a matter of concern with regard to patients receiving intensive myelosuppressive therapy for hematologic malignancies. Such infections, especially prolonged neutropenia systemic fungal infections, may contribute substantially to infectious complica